Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-044529
Filing Date
2017-07-10
Accepted
2017-07-10 14:33:23
Documents
2
Period of Report
2017-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3892
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3441
  Complete submission text file 0001209191-17-044529.txt   8830
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRONAI THERAPEUTICS, INC. 2150 - 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address
Glover Nicholas (Reporting) CIK: 0001578888 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 17957523